These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26472573)

  • 21. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
    Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?
    McIntyre D; Thiede M; Dahlgren G; Whitehead M
    Soc Sci Med; 2006 Feb; 62(4):858-65. PubMed ID: 16099574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical cost of type 2 diabetes attributable to physical inactivity in the United States in 2012.
    Shah P; Shamoon F; Bikkina M; Kohl HW
    Diabetes Metab Syndr; 2017; 11(1):13-17. PubMed ID: 27377686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
    Sato M; Ye W; Sugihara T; Isaka Y
    BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying recent findings to clinical care in type II diabetes.
    Williams R
    Pharmacoeconomics; 1995; 8 Suppl 1():80-4. PubMed ID: 10159010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review.
    Walker IF; Garbe F; Wright J; Newell I; Athiraman N; Khan N; Elsey H
    Value Health Reg Issues; 2018 May; 15():12-26. PubMed ID: 29474174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia].
    Biorac N; Jakovljević M; Stefanović D; Perović S; Janković S
    Vojnosanit Pregl; 2009 Apr; 66(4):271-6. PubMed ID: 19432292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The erosion of physical activity in Western societies: an economic death march.
    Booth FW; Hawley JA
    Diabetologia; 2015 Aug; 58(8):1730-4. PubMed ID: 25952481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic burden of physical inactivity: a global analysis of major non-communicable diseases.
    Ding D; Lawson KD; Kolbe-Alexander TL; Finkelstein EA; Katzmarzyk PT; van Mechelen W; Pratt M;
    Lancet; 2016 Sep; 388(10051):1311-24. PubMed ID: 27475266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economics of diabetes-cost impact of not treating diabetes early and intensively.
    Cefalu W
    Clin Cornerstone; 2004; 6(2):51-60. PubMed ID: 15628693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of exercise on glucose homeostasis in Type 2 diabetes mellitus.
    Kelley DE; Goodpaster BH
    Med Sci Sports Exerc; 2001 Jun; 33(6 Suppl):S495-501; discussion S528-9. PubMed ID: 11427776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review.
    Einarson TR; Acs A; Ludwig C; Panton UH
    Value Health; 2018 Jul; 21(7):881-890. PubMed ID: 30005761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden and catastrophic cost among people living with type2 diabetes mellitus attending a tertiary health institution in south-east zone, Nigeria.
    Okoronkwo IL; Ekpemiro JN; Okwor EU; Okpala PU; Adeyemo FO
    BMC Res Notes; 2015 Oct; 8():527. PubMed ID: 26429704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global policy: aspects of diabetes in India.
    Bjork S; Kapur A; King H; Nair J; Ramachandran A
    Health Policy; 2003 Oct; 66(1):61-72. PubMed ID: 14499166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physical activity and healthcare cost of type 2 diabetic patients seen at basic units of healthcare].
    Codogno JS; Fernandes RA; Monteiro HL
    Arq Bras Endocrinol Metabol; 2012 Feb; 56(1):6-11. PubMed ID: 22460189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.